2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Andrographis paniculata extract: new trials by email Literature Review of Andrographis paniculata extract trials Research Report on Andrographis paniculata extract
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects With Cognitive Impairment Andrographis and Withania, Placebo - Cognitive Impairment, Mild | Phase 1 | Completed | EuroPharma, Inc. | 16 | 2019-04-01 | 2019-11-14 |
| Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS) 1 - Andrographis paniculata p/st extract, 2 - Excipients - Multiple Sclerosis, Relapsing-Remitting | Phase 1 / Phase 2 | Completed | Universidad Austral de Chile | 30 | 2012-01-01 | 2016-06-23 |
Cognitive Dysfunction (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Nervous System Diseases (1)
EuroPharma, Inc. (1) · Universidad Austral de Chile (1)
Chile (1) · Germany (1)
Juan L. Hancke, PhD (1) · Klaus Koch, MD (1)